跳转到主要内容
搜索

早期临床

注册

最新资源

精选资源

Upcoming early clinical webinars

Latest early clinical blogs

在以下活动中与我们的专家会面

会议

MVA Oncology Network

2026 年 2 月 4 日
会议

16th Annual World ADC London 2026

February 23 - 26, 2026
现场活动

QSP Workshop 2026 in Japan & Korea – Mastering Scalable AI-enabled QSP modeling software, Certara IQ™

Japan: 2026 年 2 月 26 日 – 1:00 – 5:00 pm | Korea: 2026 年 3 月 4 日, 星期三 – 1:00 – 5:00 pm

All early clinical resources

Population Pharmacokinetics of Clesrovimabin Preterm and Full-Term Infants

Biologics, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Infectious Disease, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Pediatrics, Therapeutic Specialties, Publication

AI in Alzheimer’s drug development: Where do disease-modifying interventions go from here?

Central Nervous System (CNS), Certara Products - Certara IQ, Modeling and Simulation - QSP, New Approach Methodologies (NAMs), Blog

Opinion: To Accelerate Rare Disease Progress, Take a Sandbox Approach

Certara Services, Drug Development, Rare and Neglected Diseases, Therapeutic Specialties, Press Coverage

Modeling Population PK with Power, Speed, and Ease-of-Use (Phoenix® NLME & Pirana®)

Certara Products - Phoenix, Clinical Pharmacology, Modeling and Simulation - PK/PD, On-Demand Webinar

Leveraging the full potential of PBPK models to accelerate drug development

Certara Products - Simcyp, Drug-Drug Interactions (DDI), Model Informed Drug Development, Modeling and Simulation - PBPK, Webinar

P21 Enterprise Expands Regulatory Validation Capabilities with Support for the Tobacco Implementation Guide v1.0

CDISC, Certara Products - Pinnacle 21, Clinical Trials, Data Standards, Drug Development, Blog

Regulatory-Trusted Software for Smarter PK/PD Workflows (Phoenix WinNonlin®)

Certara Products - Phoenix, Clinical Pharmacology, Modeling and Simulation - PK/PD, On-Demand Webinar

Quantitative Systems Pharmacology Conference

Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Conference

How Model-Informed Drug Development (MIDD) Strengthens Drug Asset Valuation and Answers the Questions Investors Care About Most

Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Blog

Milliliters, Milligrams, and Moles: Keeping Up with Units in NCA

Certara Products - Phoenix, Clinical Pharmacology, Modeling and Simulation - PK/PD, Webinar

Non-compartmental analysis of statin pharmacokinetics in pharmacogenetics research

Certara Products - Phoenix, Clinical Pharmacology, Modeling and Simulation - PK/PD, Webinar

Subcutaneous absorption model

Certara Products - Phoenix, Clinical Pharmacology, Modeling and Simulation - PK/PD, Webinar
订阅时事通讯

为什么订阅？因为改变药物开发不仅是我们的目标，更是我们的执着追求。如果这也是您的想法，那么请第一时间了解新见解，与我们一起推动科学发展。


沪ICP备2022021526号
Powered by Translations.com GlobalLink Web Software